Stay updated on Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedNew navigation/help sections have been added to the page, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. The site revision badge has been updated to Revision: v3.6.0, with the older Revision: v3.5.5 removed.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page now shows Revision: v3.5.5 indicating an updated version, and no trial details or results are affected.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing the previous v3.5.3, indicating a minor internal update to the page's documentation.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page metadata/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3” without changing the study’s substantive details.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.